Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Health

India finds violations at factory linked to Gambia children deaths -state minister

FILE PHOTO: A cameraman takes visuals outside the office of Maiden Pharmaceuticals Ltd. company, in New Delhi, India, October 6, 2022. REUTERS/Anushree Fadnavis

Authorities in India have stopped production of cough syrup at a factory linked to children's deaths in Gambia after they found violations, a state minister told Reuters partner ANI on Wednesday.

Authorities said last week they were testing samples of cough syrup produced by India's Maiden Pharma for export after the World Health Organization linked them to the deaths of dozens of children in Gambia.

"State drug depts conducted a joint inspection, around 12 flaws were found, keeping which in mind, it's been decided that the total production shall be stopped," said minister Anil Vij of Haryana state, where the factory is located.

(Reporting by Shilpa Jamkhandikar; Editing by Tom Hogue)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.